Lankisch P G, Mahlke R, Blum T, Bruns A, Bruns D, Maisonneuve P, Lowenfels A B
Department of Internal Medicine, Municipal Clinic of Lüneburg, Germany.
Am J Gastroenterol. 2001 Jul;96(7):2081-5. doi: 10.1111/j.1572-0241.2001.03966.x.
A study was designed to reevaluate hemoconcentration as an early marker of severe and/or necrotizing pancreatitis and compare it against contrast-enhanced CT, the gold standard to diagnose acute necrotizing pancreatitis.
This prospective study covers the years 1988-1999 for 316 patients (202 male, 114 female) with a first attack of acute pancreatitis. The role of the hematocrit as an early marker of severe and/or necrotizing pancreatitis has been retrospectively evaluated against the prospectively obtained data. They all underwent a CT within 72 h after admission. In addition to the CT-controlled diagnosis of interstitial/necrotizing pancreatitis, the following variables were used to assess severity: initial organ failure according to the Atlanta classification; indication for artificial ventilation and/or dialysis; Ranson score adjusted for etiology; Imrie score; Balthazar score; length of stay in intensive care unit (ICU); total hospital stay; development of pancreatic pseudocysts; indication for operation (necrosectomy); and mortality. Hemoconcentration on admission was defined as a hematocrit level >43.0% for male and >39.6% for female patients. Logistic regression was used to assess the correlation between hemoconcentration and the severity of variables.
Hematocrit, as a single parameter measured on admission, had the same sensitivity and negative predictive value as the more complicated Ranson and Imrie scores obtained only after 48 h. However, its specificity, positive predictive value, and total accuracy were lower. Hemoconcentration significantly correlated with the Balthazar score (differential diagnosis between interstitial and necrotizing pancreatitis), stay in ICU, and total hospital stay. Sensitivity and specificity of the hematocrit cut-off level of 43.0% for male and 39.6% for female patients to detect necrotizing pancreatitis were 74% and 45%, respectively. The positive predictive value was 24% and the negative predictive value 88%. Receiver operation characteristics (ROC) curve values for several cut-offs did not result in more ideal levels.
Hemoconcentration does not significantly correlate with important clinical outcome variables of acute pancreatitis including organ failure and mortality rate. Its prognostic value is comparable to the more complicated Ranson and Imrie scores obtained only after 48 h. The major value of this single easily obtainable and cheap parameter on admission lies in its high negative predictive value. In the absence of hemoconcentration, contrast-enhanced CT may be unnecessary on admission unless the patient does not improve.
设计一项研究以重新评估血液浓缩作为重症和/或坏死性胰腺炎的早期标志物,并将其与诊断急性坏死性胰腺炎的金标准——增强CT进行比较。
这项前瞻性研究涵盖了1988年至1999年期间316例首次发作急性胰腺炎的患者(男性202例,女性114例)。已根据前瞻性获得的数据对血细胞比容作为重症和/或坏死性胰腺炎早期标志物的作用进行了回顾性评估。他们均在入院后72小时内接受了CT检查。除了通过CT对照诊断间质性/坏死性胰腺炎外,还使用以下变量评估严重程度:根据亚特兰大分类法的初始器官功能衰竭;人工通气和/或透析的指征;根据病因调整的兰森评分;伊姆里评分;巴尔萨泽评分;重症监护病房(ICU)住院时间;总住院时间;胰腺假性囊肿的形成;手术指征(坏死组织清除术);以及死亡率。入院时的血液浓缩定义为男性血细胞比容水平>43.0%,女性>39.6%。采用逻辑回归评估血液浓缩与各变量严重程度之间的相关性。
入院时测得的血细胞比容作为单一参数,与仅在48小时后获得的更为复杂的兰森和伊姆里评分具有相同的敏感性和阴性预测价值。然而,其特异性、阳性预测价值和总准确性较低。血液浓缩与巴尔萨泽评分(间质性和坏死性胰腺炎的鉴别诊断)、ICU住院时间和总住院时间显著相关。男性患者血细胞比容临界值为43.0%、女性患者为39.6%时检测坏死性胰腺炎的敏感性和特异性分别为74%和45%。阳性预测价值为24%,阴性预测价值为88%。几个临界值的受试者操作特征(ROC)曲线值并未得出更理想的水平。
血液浓缩与急性胰腺炎的重要临床结局变量(包括器官功能衰竭和死亡率)无显著相关性。其预后价值与仅在48小时后获得的更为复杂的兰森和伊姆里评分相当。这个入院时易于获取且廉价的单一参数的主要价值在于其较高的阴性预测价值。在没有血液浓缩的情况下,除非患者病情无改善,否则入院时可能无需进行增强CT检查。